EAM
Eventide Asset Management Portfolio holdings
AUM
$6.08B
1-Year Est. Return
64.4%
1 Year Est. Return
+64.4%
AUM
$5.71B
AUM Growth
+$688M
(+14%)
Holding
257
Top Buys
| 1 | +$28.9M | |
| 2 | +$28.5M | |
| 3 | +$27.8M | |
| 4 |
Verisk Analytics
VRSK
|
+$26M |
| 5 |
Lam Research
LRCX
|
+$25.3M |
Top Sells
| 1 | +$48.8M | |
| 2 | +$44.8M | |
| 3 | +$36.5M | |
| 4 |
Evolent Health
EVH
|
+$22.4M |
| 5 |
Inspire Medical Systems
INSP
|
+$19.4M |
Sector Composition
| 1 | Healthcare | 37.06% |
| 2 | Technology | 18.81% |
| 3 | Industrials | 18.23% |
| 4 | Consumer Discretionary | 7.45% |
| 5 | Utilities | 4.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
Relay Therapeutics
RLAY
$1.45B
| – | – |
-2,682,083
|
|
||
252
Selective Insurance
SIGI
$5.11B
| – | – |
-2,687
|
|
||
253
Sarepta Therapeutics
SRPT
$2.25B
| – | – |
-214,374
|
|
||
254
Vertex
VERX
$3.2B
| – | – |
-13,958
|
|
||
255
Viking Therapeutics
VKTX
$3.99B
| – | – |
-255,407
|
|
||
256
VYNE Therapeutics
VYNE
$18.7M
| – | – |
-1,394,336
|
|
||
257
Weave Communications
WEAV
$567M
| – | – |
-928,642
|
|